Patricia Braga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patricia Braga has a total of 219 co-authors. Here are the top co-authors by number of shared publications:
Alicia Bogacz
Epilepsy Section, Institute of Neurology, Hospital de Clínicas, Facultad de Medicina Universidad de la República Uruguay
5 shared publications- Samuel Wiebe
Department of Clinical Neurosciences, Cumming School of Medicine University of Calgary Calgary Alberta Canada
4 shared publications Janet Mifsud
Department of Clinical Pharmacology and Therapeutics Faculty of Medicine and Surgery University of Malta Msida Malta
3 shared publications- Jo M. Wilmshurst
Department of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Neuroscience Institute University of Cape Town Cape Town South Africa
3 shared publications - Judith Helen Cross
University College London National Institute for Health and Care Research Biomedical Research Centres Great Ormond Street Institute of Child Health London UK
3 shared publications Peter Wolf
Medical Sciences Post‐Graduation Program Federal University of Santa Catarina, (UFSC) Florianópolis SC Brazil
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (4) , 1126-1136
On‐site exposure to clinical epilepsy practice for experimental scientists engaged in epilepsy research: A pilot study by the ILAE commission on neurobiology
Educational initiatives that address the gap between basic/preclinical and clinical practices are important to effectively translate basic science discoveries to benefit patients. The ILAE Neurobiology Commission conducted a pilot project aimed at exposing basic and preclinical scientists engaged in epilepsy research to general clinical issues pertaining to the diagnosis and care of people with epilepsy. This aim was addressed through a two‐week‐long, on‐site clinical training program for 50 basic scientists in 21 epilepsy centers across 18 countries in the six ILAE regions (with a maximum of 3 basic scientists per center). The learning objectives and the training module were discussed and defined by the project organizing committee, which consisted of Neurobiology Commission members and a team of epileptologists representing different geographical regions. The training activities were conducted at each epilepsy center under the local supervision of clinical tutors. Each basic scientist was exposed to 50.3 ± 23.3 (range 16–89) hours of intensive and dedicated clinical training, coordinated by 2–3 tutors per center, assisted by 6.8 ± 3.6 colleagues. A structured test consisting of 17 general clinical epilepsy questions was completed by the trainees before and after the training activity. The learning assessment was based on the comparison between responses to the exit and entry tests. After the on‐site clinical exposure, the proportion of correct answers increased to 87% compared to 61% in the entry test. Structured post‐training questionnaires demonstrated very high satisfaction of trainees and all involved tutors across the different aspects of the training module. This global pilot study demonstrated that on‐site attendance by basic scientists in specialized clinical settings up‐scaled their knowledge of clinical epileptology and facilitated networking with clinicians. Expansion of this pilot to further centers should be considered to understand how exposure to clinical practice affects research direction and quality of translational epilepsy research. Plain Language Summary: Epilepsy research has long benefitted from collaboration between scientists and clinicians. Early exposure of researchers to people with epilepsy and their care teams may strengthen future impact. This pilot study tested a two‐week immersive experience where small teams of basic scientists shadowed clinicians during their work at hospitals around the world. Questionnaires showed high satisfaction among both groups. Results support expanding such training, with the backing of the International League Against epilepsy and aligned centers, to build understanding, interest, and long‐term commitment, ensuring bench research is informed by and translates to clinical practice and improved quality of life for patients.
- 1 June 2026
- Published by Wiley in Epilepsia Open
- Vol. 11 (4) , 1126-1136
Open AccessOn‐site exposure to clinical epilepsy practice for experimental scientists engaged in epilepsy research: A pilot study by the ILAE commission on neurobiology
Educational initiatives that address the gap between basic/preclinical and clinical practices are important to effectively translate basic science discoveries to benefit patients. The ILAE Neurobiology Commission conducted a pilot project aimed at exposing basic and preclinical scientists engaged in epilepsy research to general clinical issues pertaining to the diagnosis and care of people with epilepsy. This aim was addressed through a two‐week‐long, on‐site clinical training program for 50 basic scientists in 21 epilepsy centers across 18 countries in the six ILAE regions (with a maximum of 3 basic scientists per center). The learning objectives and the training module were discussed and defined by the project organizing committee, which consisted of Neurobiology Commission members and a team of epileptologists representing different geographical regions. The training activities were conducted at each epilepsy center under the local supervision of clinical tutors. Each basic scientist was exposed to 50.3 ± 23.3 (range 16–89) hours of intensive and dedicated clinical training, coordinated by 2–3 tutors per center, assisted by 6.8 ± 3.6 colleagues. A structured test consisting of 17 general clinical epilepsy questions was completed by the trainees before and after the training activity. The learning assessment was based on the comparison between responses to the exit and entry tests. After the on‐site clinical exposure, the proportion of correct answers increased to 87% compared to 61% in the entry test. Structured post‐training questionnaires demonstrated very high satisfaction of trainees and all involved tutors across the different aspects of the training module. This global pilot study demonstrated that on‐site attendance by basic scientists in specialized clinical settings up‐scaled their knowledge of clinical epileptology and facilitated networking with clinicians. Expansion of this pilot to further centers should be considered to understand how exposure to clinical practice affects research direction and quality of translational epilepsy research. Plain Language Summary: Epilepsy research has long benefitted from collaboration between scientists and clinicians. Early exposure of researchers to people with epilepsy and their care teams may strengthen future impact. This pilot study tested a two‐week immersive experience where small teams of basic scientists shadowed clinicians during their work at hospitals around the world. Questionnaires showed high satisfaction among both groups. Results support expanding such training, with the backing of the International League Against epilepsy and aligned centers, to build understanding, interest, and long‐term commitment, ensuring bench research is informed by and translates to clinical practice and improved quality of life for patients.
- 10 May 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 139, 182-192
Etiology of active epilepsy in adults: A Latin American multicenter hospital-based study
- 10 May 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 139, 182-192
Etiology of active epilepsy in adults: A Latin American multicenter hospital-based study
- 1 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 173, 110571
Characterization of uncertainty in illness in adult epilepsy patients
- 1 July 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 173, 110571
Characterization of uncertainty in illness in adult epilepsy patients
- Open Access
- 31 January 2025
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 41 (1)
Evaluación de respuesta electroencefalográfica en actividad física aeróbica y técnicas de relajación en pacientes con epilepsia
Introducción: El impacto de la actividad física en las crisis epilépticas y descargas epileptiformes interictales (DEI) es controvertido. Nos propusimos evaluar la eventual modulación de DEI en pacientes con epilepsia durante diferentes tipos de actividad física (ejercicio aeróbico no extenuante, técnicas de relajación) Metodología: Estudio cuasiexperimental, en adultos con epilepsia activa, con un protocolo de 5 períodos de 15 minutos, bajo EEG: reposo, ejercicio aeróbico (EA) con Ruffier-Dickson modificado, post-ejercicio (PEA), técnicas de relajación activa (RA) con Jacobson y Biofeedback, y post-RA. Se contabilizaron DEI en ventanas de 3 minutos, realizando comparación intraindividual entre períodos (ANOVA), y con el basal (95%IC de la diferencia). Se analizó la variación de la frecuencia cardíaca en EA y coherencia cardíaca en biofeedback. Resultados: Incluimos 20 pacientes, (M11/F9), 30+7años, 18 con epilepsia focal, 55% farmacorresistentes. 8/13 pacientes con DEI presentaron modulación. Comparados con reposo, 3 (20%) tenían inhibición significativa en EA y 1 post-RA.; presentaron activación 1 durante RA y 2 post-RA. En la comparación intraindividual 5 activaron post-EA vs EA (26.5%) y 2 inhibieron Post-RA vs RA. Tres pacientes con insuficiente coherencia cardíaca en biofeedback presentaron baja variación de frecuencia cardíaca en EA. Discusión: La disminución de DEIs durante el EA es acorde a otros trabajos, en tanto el aumento de DEI post-ejercicio puede relacionarse con las crisis del período de relajación vespertino frecuente en la clínica. Este protocolo de relajación activa raramente modificó las DEI. Conclusiones: La actividad física aeróbica no-extenuante puede tener un efecto favorable en el control de la epilepsia.
- 31 January 2025
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 41 (1)
Open AccessEvaluación de respuesta electroencefalográfica en actividad física aeróbica y técnicas de relajación en pacientes con epilepsia
Introducción: El impacto de la actividad física en las crisis epilépticas y descargas epileptiformes interictales (DEI) es controvertido. Nos propusimos evaluar la eventual modulación de DEI en pacientes con epilepsia durante diferentes tipos de actividad física (ejercicio aeróbico no extenuante, técnicas de relajación) Metodología: Estudio cuasiexperimental, en adultos con epilepsia activa, con un protocolo de 5 períodos de 15 minutos, bajo EEG: reposo, ejercicio aeróbico (EA) con Ruffier-Dickson modificado, post-ejercicio (PEA), técnicas de relajación activa (RA) con Jacobson y Biofeedback, y post-RA. Se contabilizaron DEI en ventanas de 3 minutos, realizando comparación intraindividual entre períodos (ANOVA), y con el basal (95%IC de la diferencia). Se analizó la variación de la frecuencia cardíaca en EA y coherencia cardíaca en biofeedback. Resultados: Incluimos 20 pacientes, (M11/F9), 30+7años, 18 con epilepsia focal, 55% farmacorresistentes. 8/13 pacientes con DEI presentaron modulación. Comparados con reposo, 3 (20%) tenían inhibición significativa en EA y 1 post-RA.; presentaron activación 1 durante RA y 2 post-RA. En la comparación intraindividual 5 activaron post-EA vs EA (26.5%) y 2 inhibieron Post-RA vs RA. Tres pacientes con insuficiente coherencia cardíaca en biofeedback presentaron baja variación de frecuencia cardíaca en EA. Discusión: La disminución de DEIs durante el EA es acorde a otros trabajos, en tanto el aumento de DEI post-ejercicio puede relacionarse con las crisis del período de relajación vespertino frecuente en la clínica. Este protocolo de relajación activa raramente modificó las DEI. Conclusiones: La actividad física aeróbica no-extenuante puede tener un efecto favorable en el control de la epilepsia.
- Open Access
- 26 June 2024
- Published by Wiley in Epileptic Disorders
- Vol. 26 (5) , 638-650
The international league against epilepsy primary healthcare educational curriculum: Assessment of educational needs
Objective: To assess the need for an epilepsy educational curriculum for primary healthcare providers formulated by the International League Against Epilepsy (ILAE) and the importance attributed to its competencies by epilepsy specialists and primary care providers and across country‐income settings.Methods: The ILAE primary care epilepsy curriculum was translated to five languages. A structured questionnaire assessing the importance of its 26 curricular competencies was posted online and publicized widely to an international community. Respondents included epilepsy specialists, primary care providers, and others from three World Bank country‐income categories. Responses from different groups were compared with univariate and ordinal logistic regression analyses.Results: Of 785 respondents, 60% noted that a primary care epilepsy curriculum did not exist or they were unaware of one in their country. Median ranks of importance for all competencies were high (very important to extremely important) in the entire sample and across different groups. Fewer primary care providers than specialists rated the following competencies as extremely important: definition of epilepsy (p = .03), recognition of seizure mimics (p = .02), interpretation of test results for epilepsy care (p = .001), identification of drug‐resistant epilepsy (0.005) and management of psychiatric comorbidities (0.05). Likewise, fewer respondents from LMICs in comparison to UMICs rated 15 competencies as extremely important.Significance: The survey underscores the unmet need for an epilepsy curriculum in primary care and the relevance of its competencies across different vocational and socioeconomic settings. Differences across vocational and country income groups indicate that educational packages should be developed and adapted to needs in different settings.
- 26 June 2024
- Published by Wiley in Epileptic Disorders
- Vol. 26 (5) , 638-650
Open AccessThe international league against epilepsy primary healthcare educational curriculum: Assessment of educational needs
Objective: To assess the need for an epilepsy educational curriculum for primary healthcare providers formulated by the International League Against Epilepsy (ILAE) and the importance attributed to its competencies by epilepsy specialists and primary care providers and across country‐income settings.Methods: The ILAE primary care epilepsy curriculum was translated to five languages. A structured questionnaire assessing the importance of its 26 curricular competencies was posted online and publicized widely to an international community. Respondents included epilepsy specialists, primary care providers, and others from three World Bank country‐income categories. Responses from different groups were compared with univariate and ordinal logistic regression analyses.Results: Of 785 respondents, 60% noted that a primary care epilepsy curriculum did not exist or they were unaware of one in their country. Median ranks of importance for all competencies were high (very important to extremely important) in the entire sample and across different groups. Fewer primary care providers than specialists rated the following competencies as extremely important: definition of epilepsy (p = .03), recognition of seizure mimics (p = .02), interpretation of test results for epilepsy care (p = .001), identification of drug‐resistant epilepsy (0.005) and management of psychiatric comorbidities (0.05). Likewise, fewer respondents from LMICs in comparison to UMICs rated 15 competencies as extremely important.Significance: The survey underscores the unmet need for an epilepsy curriculum in primary care and the relevance of its competencies across different vocational and socioeconomic settings. Differences across vocational and country income groups indicate that educational packages should be developed and adapted to needs in different settings.
- Open Access
Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper
A variety of terms, such as “antiepileptic,” “anticonvulsant,” and “antiseizure” have been historically applied to medications for the treatment of seizure disorders. Terminology is important because using terms that do not accurately reflect the action of specific treatments may result in a misunderstanding of their effects and inappropriate use. The present International League Against Epilepsy (ILAE) position paper used a Delphi approach to develop recommendations on English‐language terminology applicable to pharmacological agents currently approved for treating seizure disorders. There was consensus that these medications should be collectively named “antiseizure medications”. This term accurately reflects their primarily symptomatic effect against seizures and reduces the possibility of health care practitioners, patients, or caregivers having undue expectations or an incorrect understanding of the real action of these medications. The term “antiseizure” to describe these agents does not exclude the possibility of beneficial effects on the course of the disease and comorbidities that result from the downstream effects of seizures, whenever these beneficial effects can be explained solely by the suppression of seizure activity. It is acknowledged that other treatments, mostly under development, can exert direct favorable actions on the underlying disease or its progression, by having “antiepileptogenic” or “disease‐modifying” effects. A more‐refined terminology to describe precisely these actions needs to be developed.
Open AccessWhich terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper
A variety of terms, such as “antiepileptic,” “anticonvulsant,” and “antiseizure” have been historically applied to medications for the treatment of seizure disorders. Terminology is important because using terms that do not accurately reflect the action of specific treatments may result in a misunderstanding of their effects and inappropriate use. The present International League Against Epilepsy (ILAE) position paper used a Delphi approach to develop recommendations on English‐language terminology applicable to pharmacological agents currently approved for treating seizure disorders. There was consensus that these medications should be collectively named “antiseizure medications”. This term accurately reflects their primarily symptomatic effect against seizures and reduces the possibility of health care practitioners, patients, or caregivers having undue expectations or an incorrect understanding of the real action of these medications. The term “antiseizure” to describe these agents does not exclude the possibility of beneficial effects on the course of the disease and comorbidities that result from the downstream effects of seizures, whenever these beneficial effects can be explained solely by the suppression of seizure activity. It is acknowledged that other treatments, mostly under development, can exert direct favorable actions on the underlying disease or its progression, by having “antiepileptogenic” or “disease‐modifying” effects. A more‐refined terminology to describe precisely these actions needs to be developed.
- 1 February 2023
- Published by Wiley in Epileptic Disorders
- Vol. 25 (1) , 104-109
Association of ictal aphasia with hypoperfusion in language areas in temporal lobe epilepsy patients
Ictal clinical phenomenology, including aphasia, is usually associated with increased regional cerebral perfusion. We present an unusual pattern of ictal cerebral perfusion in three patients with pharmacoresistant, lesional temporal lobe epilepsy and ictal/postictal aphasia studied with prolonged video-EEG, ictal, and interictal SPECT and MRI for pre-surgical evaluation. Subtraction of ictal-interictal SPECT images co-registered with MRI (SISCOM) showed ictal hyperperfusion in the temporal epileptogenic area in all patients. In addition, hypoperfusion of Broca's area in one case, Wernicke's area in other patient, and both areas in the remaining one were observed. Ictal aphasia in these patients may be explained by functional inhibition of a primary language area, driven by the epileptogenic network. This pattern can contribute to understand the pathophysiology of some ictal signs, with an impact on the evaluation of individual surgical risks.
- 1 February 2023
- Published by Wiley in Epileptic Disorders
- Vol. 25 (1) , 104-109
Association of ictal aphasia with hypoperfusion in language areas in temporal lobe epilepsy patients
Ictal clinical phenomenology, including aphasia, is usually associated with increased regional cerebral perfusion. We present an unusual pattern of ictal cerebral perfusion in three patients with pharmacoresistant, lesional temporal lobe epilepsy and ictal/postictal aphasia studied with prolonged video-EEG, ictal, and interictal SPECT and MRI for pre-surgical evaluation. Subtraction of ictal-interictal SPECT images co-registered with MRI (SISCOM) showed ictal hyperperfusion in the temporal epileptogenic area in all patients. In addition, hypoperfusion of Broca's area in one case, Wernicke's area in other patient, and both areas in the remaining one were observed. Ictal aphasia in these patients may be explained by functional inhibition of a primary language area, driven by the epileptogenic network. This pattern can contribute to understand the pathophysiology of some ictal signs, with an impact on the evaluation of individual surgical risks.
Systematic review of frequency of felt and enacted stigma in epilepsy and determining factors and attitudes toward persons living with epilepsy—Report from the International League Against Epilepsy Task Force on Stigma in Epilepsy
Objective: To review the evidence of felt and enacted stigma and attitudes toward persons living with epilepsy, and their determining factors.Methods: Thirteen databases were searched (1985–2019). Abstracts were reviewed in duplicate and data were independently extracted using a standardized form. Studies were characterized using descriptive analysis by whether they addressed “felt” or “enacted” stigma and “attitudes” toward persons living with epilepsy.Results: Of 4234 abstracts, 132 met eligibility criteria and addressed either felt or enacted stigma and 210 attitudes toward epilepsy. Stigma frequency ranged broadly between regions. Factors associated with enacted stigma included low level of knowledge about epilepsy, lower educational level, lower socioeconomic status, rural areas living, and religious grouping. Negative stereotypes were often internalized by persons with epilepsy, who saw themselves as having an “undesirable difference” and so anticipated being treated differently. Felt stigma was associated with increased risk of psychological difficulties and impaired quality of life. Felt stigma was linked to higher seizure frequency, recency of seizures, younger age at epilepsy onset or longer duration, lower educational level, poorer knowledge about epilepsy, and younger age. An important finding was the potential contribution of epilepsy terminology to the production of stigma. Negative attitudes toward those with epilepsy were described in 100% of included studies, and originated in any population group (students, teachers, healthcare professionals, general public, and those living with epilepsy). Better attitudes were generally noted in those of younger age or higher educational status.Significance: Whatever the specific beliefs about epilepsy, implications for felt and enacted stigma show considerable commonality worldwide. Although some studies show improvement in attitudes toward those living with epilepsy over time, much work remains to be done to improve attitudes and understand the true occurrence of discrimination against persons with epilepsy.
Systematic review of frequency of felt and enacted stigma in epilepsy and determining factors and attitudes toward persons living with epilepsy—Report from the International League Against Epilepsy Task Force on Stigma in Epilepsy
Objective: To review the evidence of felt and enacted stigma and attitudes toward persons living with epilepsy, and their determining factors.Methods: Thirteen databases were searched (1985–2019). Abstracts were reviewed in duplicate and data were independently extracted using a standardized form. Studies were characterized using descriptive analysis by whether they addressed “felt” or “enacted” stigma and “attitudes” toward persons living with epilepsy.Results: Of 4234 abstracts, 132 met eligibility criteria and addressed either felt or enacted stigma and 210 attitudes toward epilepsy. Stigma frequency ranged broadly between regions. Factors associated with enacted stigma included low level of knowledge about epilepsy, lower educational level, lower socioeconomic status, rural areas living, and religious grouping. Negative stereotypes were often internalized by persons with epilepsy, who saw themselves as having an “undesirable difference” and so anticipated being treated differently. Felt stigma was associated with increased risk of psychological difficulties and impaired quality of life. Felt stigma was linked to higher seizure frequency, recency of seizures, younger age at epilepsy onset or longer duration, lower educational level, poorer knowledge about epilepsy, and younger age. An important finding was the potential contribution of epilepsy terminology to the production of stigma. Negative attitudes toward those with epilepsy were described in 100% of included studies, and originated in any population group (students, teachers, healthcare professionals, general public, and those living with epilepsy). Better attitudes were generally noted in those of younger age or higher educational status.Significance: Whatever the specific beliefs about epilepsy, implications for felt and enacted stigma show considerable commonality worldwide. Although some studies show improvement in attitudes toward those living with epilepsy over time, much work remains to be done to improve attitudes and understand the true occurrence of discrimination against persons with epilepsy.
Epilepsy‐related stigma and attitudes: Systematic review of screening instruments and interventions ‐ Report by the International League Against Epilepsy Task Force on Stigma in Epilepsy
Summary: Objective: This is a systematic review aimed at summarizing the evidence related to instruments that have been developed to measure stigma or attitudes toward epilepsy and on stigma‐reducing interventions.Methods: This review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) standards. A broad literature search (1985–2019) was performed in 13 databases. Articles were included if they described the development and testing of psychometric properties of an epilepsy‐related stigma or attitude scale or stigma‐reducing interventions. Two reviewers independently screened abstracts, reviewed full‐text articles, and extracted data. Basic descriptive statistics are reported.Results: We identified 4234 abstracts, of which 893 were reviewed as full‐text articles. Of these, 38 met inclusion criteria for an instrument development study and 30 as a stigma‐reduction intervention study. Most instruments were initially developed using well‐established methods and were tested in relatively large samples. Most intervention studies involved educational programs for adults with pre‐ and post‐evaluations of attitudes toward people with epilepsy. Intervention studies often failed to use standardized instruments to quantify stigmatizing attitudes, were generally underpowered, and often found no evidence of benefit or the benefit was not sustained. Six intervention studies with stigma as the primary outcome had fewer design flaws and showed benefit. Very few or no instruments were validated for regional languages or culture, and there were very few interventions tested in some regions.Significance: Investigators in regions without instruments should consider translating and further developing existing instruments rather than initiating the development of new instruments. Very few stigma‐reduction intervention studies for epilepsy have been conducted, study methodology in general was poor, and standardized instruments were rarely used to measure outcomes. To accelerate the development of effective epilepsy stigma‐reduction interventions, a paradigm shift from disease‐specific, siloed trials to collaborative, cross‐disciplinary platforms based upon unified theories of stigma transcending individual conditions will be needed.
Epilepsy‐related stigma and attitudes: Systematic review of screening instruments and interventions ‐ Report by the International League Against Epilepsy Task Force on Stigma in Epilepsy
Summary: Objective: This is a systematic review aimed at summarizing the evidence related to instruments that have been developed to measure stigma or attitudes toward epilepsy and on stigma‐reducing interventions.Methods: This review followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) standards. A broad literature search (1985–2019) was performed in 13 databases. Articles were included if they described the development and testing of psychometric properties of an epilepsy‐related stigma or attitude scale or stigma‐reducing interventions. Two reviewers independently screened abstracts, reviewed full‐text articles, and extracted data. Basic descriptive statistics are reported.Results: We identified 4234 abstracts, of which 893 were reviewed as full‐text articles. Of these, 38 met inclusion criteria for an instrument development study and 30 as a stigma‐reduction intervention study. Most instruments were initially developed using well‐established methods and were tested in relatively large samples. Most intervention studies involved educational programs for adults with pre‐ and post‐evaluations of attitudes toward people with epilepsy. Intervention studies often failed to use standardized instruments to quantify stigmatizing attitudes, were generally underpowered, and often found no evidence of benefit or the benefit was not sustained. Six intervention studies with stigma as the primary outcome had fewer design flaws and showed benefit. Very few or no instruments were validated for regional languages or culture, and there were very few interventions tested in some regions.Significance: Investigators in regions without instruments should consider translating and further developing existing instruments rather than initiating the development of new instruments. Very few stigma‐reduction intervention studies for epilepsy have been conducted, study methodology in general was poor, and standardized instruments were rarely used to measure outcomes. To accelerate the development of effective epilepsy stigma‐reduction interventions, a paradigm shift from disease‐specific, siloed trials to collaborative, cross‐disciplinary platforms based upon unified theories of stigma transcending individual conditions will be needed.
- 1 August 2021
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 90, 182-185
Exploring quality of life perception in people with epilepsy and people imagining life with epilepsy
- 1 August 2021
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 90, 182-185
Exploring quality of life perception in people with epilepsy and people imagining life with epilepsy